- Rating
- 2
- Confidence
- 2
- Informativeness
- 2
- Presentation
- 1
- Soundness
- 2
Read review
Paper summary
The authors have tackled a relevant real-life problem - treatment response prediction in multimodal settings face challenges of using varying historical context and diverse modalities which can be clinical, imaging or treatment related. They model concurrent and sequential relations, and evaluate on data across countries and cohorts.
Critical strengths
-
The problem is practically motivated.
-
Ablations across modalities are conducted.
-
Results are reported on public dataset and private ones.
Critical weaknesses
The writing is hard to follow along, and does not provide adequate context. I would encourage the authors to consider simplifying the introduction to make the motivation and contributions more clear and accessible to the broader community. Broader comparisons against benchmarks like [1] would also be good to add.
Questions for authors
-
In section 2.1, please add examples wherever possible to make the draft easier to read
-
What does “unresolved regimens” mean in section 2.2?
-
Why have separate experts instead of combining experts of individual inputs as needed?
-
How does the proposed model compare against [1]? Is this infeasible for some reason?
-
Table 1 shows a high variance across methods and dataset - is there a reason for this? Can it be alleviated?
-
Table 2 shows that “without I” does quite well - is there any intuition for this?
[1] Tang, W., Jin, C., Kong, Q., Liu, C., Chen, S., Ding, S., ... & Guo, Y. (2025). Development and validation of an MRI spatiotemporal interaction model for early noninvasive prediction of neoadjuvant chemotherapy response in breast cancer: a multicentre study. EClinicalMedicine, 85.